We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00148785
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : November 11, 2013
Information provided by (Responsible Party):
Ighovwerha Ofotokun, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : January 2007